Charles Sermon
General Counsel
Mereo BioPharma Group plc (MREO)Equibles does not estimate personal net worth.
Get an email with a short summary when Mereo BioPharma Group plc publishes a filing, an earnings call transcript or a press release.
Get MREO alertsAbout Charles Sermon
Charles Sermon is recorded as General Counsel at Mereo BioPharma Group plc (MREO). The newest filing on record that lists Charles Sermon as General Counsel at Mereo BioPharma Group plc (MREO) is dated April 9, 2026. The proxy statement of Mereo BioPharma Group plc reports total compensation of $1,088,249 for Charles Sermon in fiscal 2023, including a base salary of $415,651. Disclosed compensation is on record for 2 fiscal years. Mereo BioPharma Group plc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Mereo BioPharma Group plc includes Dr. Denise Scots-Knight (CEO and Board Member), Michael S. Wyzga (Chairman), Christine Fox (CFO) and 7 others.
Affiliation history
-
Current
Start not stated–present
Last confirmed April 9, 2026
Company network
Leadership on record at Mereo BioPharma Group plc
- Dr. Denise Scots-Knight CEO, Board Member
- Michael S. Wyzga Chairman
- Christine Fox CFO
- Dr. Anders Ekblom Board Member
- Dr. Annalisa Jenkins Board Member
- Dr. Daniel Shames Board Member
- Dr. Deepika R. Pakianathan Board Member
- Dr. Jeremy Bender Board Member
- Dr. Pierre Jacquet Board Member
- Justin Roberts Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Mereo BioPharma Group plc (MREO) | General Counsel | $415,651 | $1,088,249 |
| 2022 | Mereo BioPharma Group plc (MREO) | General Counsel | $372,772 | $949,889 |
Recent activity
No call appearances or filed executive changes recorded yet.